1H-PYRAZOLO[3,4-b]PYRIDINES AND THERAPEUTIC USES THEREOF

PROBLEM TO BE SOLVED: To provide novel compounds, and pharmaceutical compositions comprising the compounds, useful in treating a disorder or disease in which aberrant Wnt signaling is implicated, such as cancer, pulmonary fibrosis, idiopathic pulmonary fibrosis, diabetic retinopathy, rheumatoid arth...

Full description

Saved in:
Bibliographic Details
Main Authors DAVID MARK WALLACE, HOOD JOHN, SUNIL KUMAR KC
Format Patent
LanguageEnglish
Japanese
Published 18.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide novel compounds, and pharmaceutical compositions comprising the compounds, useful in treating a disorder or disease in which aberrant Wnt signaling is implicated, such as cancer, pulmonary fibrosis, idiopathic pulmonary fibrosis, diabetic retinopathy, rheumatoid arthritis, scleroderma, mycotic and viral infections, osteochondropathy, Alzheimer's disease, dementia, and Parkinson's disease.SOLUTION: The present invention provides: compounds having a 1H-pyrazolo[3,4-b]pyridine skeleton represented by the compound in the figure; and pharmaceutical compositions comprising the compounds.SELECTED DRAWING: None 【課題】癌、肺線維症、突発性肺線維症、糖尿病性網膜症、関節リウマチ、強皮症、真菌又はウイルス感染症、骨又は軟骨疾患、アルツハイマー病、認知症、パーキンソン病など、異常なWntシグナル伝達が関係する障害又は疾患を処置に有用な新規化合物、及び該化合物を含有する医薬組成物の提供。【解決手段】下記化合物を代表例とする1H−ピラゾロ[3,4−b]ピリジン骨格を有する化合物、及び該化合物を含有する医薬組成物。【選択図】なし
AbstractList PROBLEM TO BE SOLVED: To provide novel compounds, and pharmaceutical compositions comprising the compounds, useful in treating a disorder or disease in which aberrant Wnt signaling is implicated, such as cancer, pulmonary fibrosis, idiopathic pulmonary fibrosis, diabetic retinopathy, rheumatoid arthritis, scleroderma, mycotic and viral infections, osteochondropathy, Alzheimer's disease, dementia, and Parkinson's disease.SOLUTION: The present invention provides: compounds having a 1H-pyrazolo[3,4-b]pyridine skeleton represented by the compound in the figure; and pharmaceutical compositions comprising the compounds.SELECTED DRAWING: None 【課題】癌、肺線維症、突発性肺線維症、糖尿病性網膜症、関節リウマチ、強皮症、真菌又はウイルス感染症、骨又は軟骨疾患、アルツハイマー病、認知症、パーキンソン病など、異常なWntシグナル伝達が関係する障害又は疾患を処置に有用な新規化合物、及び該化合物を含有する医薬組成物の提供。【解決手段】下記化合物を代表例とする1H−ピラゾロ[3,4−b]ピリジン骨格を有する化合物、及び該化合物を含有する医薬組成物。【選択図】なし
Author SUNIL KUMAR KC
DAVID MARK WALLACE
HOOD JOHN
Author_xml – fullname: DAVID MARK WALLACE
– fullname: HOOD JOHN
– fullname: SUNIL KUMAR KC
BookMark eNrjYmDJy89L5WSwMPTQDYgMcozy9_GPNtYx0U2KBXI9XTz9XIMVHP1cFEI8XIMcA1xDQzydFUKDgYIgAVd_Nx4G1rTEnOJUXijNzaDk5hri7KGbWpAfn1pckJicmpdaEu8VYGRgaGFoZmRsZOxoTJQiANi6Kt4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 1H−ピラゾロ[3,4−b]ピリジンおよびそれらの治療的使用
ExternalDocumentID JP2018162323A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2018162323A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:12:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2018162323A3
Notes Application Number: JP20180139863
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181018&DB=EPODOC&CC=JP&NR=2018162323A
ParticipantIDs epo_espacenet_JP2018162323A
PublicationCentury 2000
PublicationDate 20181018
PublicationDateYYYYMMDD 2018-10-18
PublicationDate_xml – month: 10
  year: 2018
  text: 20181018
  day: 18
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies SAMUMED LLC
RelatedCompanies_xml – name: SAMUMED LLC
Score 3.2917457
Snippet PROBLEM TO BE SOLVED: To provide novel compounds, and pharmaceutical compositions comprising the compounds, useful in treating a disorder or disease in which...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 1H-PYRAZOLO[3,4-b]PYRIDINES AND THERAPEUTIC USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181018&DB=EPODOC&locale=&CC=JP&NR=2018162323A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1DedijqVItIng7bp50ORrh90xbWldDKVMdKPgQrbcBX_vknsdE97y93BcQncXZL7ArjRCnMqT4sCGblWIUW6L1EuaxiRSlblKesPzgPtg0gLhko4Ukct-FjVwvA-od-8OSLVqILqe83t9eL_E8vluZXLu_yNouYPfma5YvM6lli7KkN0e5aXxG7siI5jhYkYpb806uplbG_BNr1H6yz_y3vqsbKUxbpP8Q9gJ6HsZvUhtN5JB_ac1ei1DuwOmog3XTbKtzwCQwpQ8pzaL_Fj_IpvFZSPKdh32dwMwY5cIQu81E68YdZ3hCG1kxzhxf4xXPte5gSIijD52_AkTNbExSfQns1n1SkIqk5ISVRcmqqpqBI29FJRdFJVJC8wlo0z6G5gdL6R2oV9BjGzLBkX0K4_v6pL6m_r_Iqf0w-45n5O
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0WkTwZt03bZQ5GuH3Rza8voZE5kpB8DFbrhKv77JnHTPe0tuYPjEri7JJf7HcCNkbam6jRNEUmMHGnKfYYS1cCI5qquTjk-uEi09wPDH2rdkT6qwMeqFkbghH4LcERmUSmz91L46_n_I5Yj_lYu7pI3Rpo9eLHpyMvbscLhqojstE03Cp3Qlm3b7EZyMPjlsVCvYmsLttkZm3CgffepzctS5usxxduHnYiJK8oDqLzTOtTsVeu1Ouz2lxlvNlwa3-IQiOKj6HlgjcNe-IJvNZS8smnH4X0zJCtwpNh3B1bkDuOOLQ2ZnxQEN_SO4NpzY9tHTIXJ34In3WhNXXwM1WJW5Ccg6U1KM6rjrKW3NF3BpJlpWpPmOU1SjFVyCo0Ngs42cq-g5sf93qTXCR4bsMc53EUr5Byq5edXfsFib5lcij37AczygT4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1H-PYRAZOLO%5B3%2C4-b%5DPYRIDINES+AND+THERAPEUTIC+USES+THEREOF&rft.inventor=DAVID+MARK+WALLACE&rft.inventor=HOOD+JOHN&rft.inventor=SUNIL+KUMAR+KC&rft.date=2018-10-18&rft.externalDBID=A&rft.externalDocID=JP2018162323A